A clinical study NERUNJI VER KUDINEER for KALLADAIPPU[Urolithiasis]
Phase 2
- Conditions
- Health Condition 1: null- KALLADAIPP
- Registration Number
- CTRI/2018/03/012710
- Lead Sponsor
- Dr S Neelavathi MD PhD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age from 30 years to 60 years Patient With Renal Colicky pain Nausea Vomiting
Haematuria Oliguria Pyuria Dysuria
Exclusion Criteria
Age Below 30 years and above 60 years Chronic Appendicitis Cholecystitis Pyelonephritis Recurrent UTI Diabetes Mellitus Metabolic disorders like Hyperthyroidism Hyperparathyroidism
Pelvic Inflammatory Disease Chronic Renal Failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therapeutic efficacy of taial drug NERUNJI VER KUDINEER in KALLADAIPPUTimepoint: 30 days
- Secondary Outcome Measures
Name Time Method Evaluation of Sidhha diagnostic parameters safety of trial drug Pharmacological and Biochemical analysis of trial drugTimepoint: 30 days